We revise our estimates for FY20-22E and now value the stock at 0.64x FY22E BVPS, with a revised target price of Rs. 62 and continue to recommend ACCUMULATE rating on the stock. Corona update and impact on industry Corona virus pandemic continues to disrupt economy throughout the world, as the number of infected people globally reached +1.4mn (~75k deaths) spread across 120 affected nations. IMF cut the CY20 world growth estimates by 40bps to 2.9%. Moody's reduced their GDP forecasts for India to 2.5% from 5.3% earlier for CY20 and S&P;...